Osmotica pharmaceuticals plc (OSMT)
Income statement / Yearly
Dec'19Dec'18Dec'17
Revenues

240,031

263,701

245,749

Cost of goods sold (inclusive of amortization of intangibles)

111,630

140,082

125,188

Gross profit

128,401

123,619

120,560

Selling, general and administrative expenses

93,030

74,243

56,954

Research and development expenses

32,319

43,693

42,688

Impairment of intangibles

283,747

17,903

-

Impairment of intangibles and fixed assets

-

-

72,986

Impairment of goodwill

0

86,318

0

Total operating expenses

409,096

222,157

172,628

Operating loss

-280,695

-98,538

-52,068

Interest expense and amortization of debt discount

18,211

20,790

29,052

Other non-operating (income) loss, net

-

-

-4,521

Other non-operating expense

884

664

-33,574

Total other non-operating expense (gain)

-17,327

-20,126

-

Loss before income taxes

-298,022

-118,664

-85,642

Income tax benefit

-27,121

-8,983

-44,500

Net loss

-270,901

-109,681

-41,141

Other comprehensive loss, net
Change in foreign currency translation adjustments

-383

-1,213

-907

Comprehensive loss

-271,284

-110,894

-42,049

Income (loss) per share attributable to shareholders
Loss per share attributable to shareholders, basic and diluted

-5.17

-2.42

-

Partnership income (loss) per unit

-

-

-0.96

Diluted

-

-

-0.96

Weighted average shares basic and diluted
Weighted average shares, basic and diluted

52,367

45,276

-

Basic and Diluted

-

-

42,855

Product Revenue
Revenues

235,472

261,398

237,671

Royalty Revenue
Revenues

3,641

1,959

6,449

Licensing and Contract Revenue
Revenues

918

344

1,628